Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.

Zulfiqar O, Ali T, Mohayy Ud Din G, Babar ZUD, Zarif S

Open source

DOI
10.7759/cureus.109528
Published
2026 May
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.109528,
  title = {Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.},
  author = {Zulfiqar O and Ali T and Mohayy Ud Din G and Babar ZUD and Zarif S},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.109528},
  url = {https://doi.org/10.7759/cureus.109528}
}

RIS

TY  - JOUR
TI  - Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.
AU  - Zulfiqar O
AU  - Ali T
AU  - Mohayy Ud Din G
AU  - Babar ZUD
AU  - Zarif S
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.109528
UR  - https://doi.org/10.7759/cureus.109528
ER  - 

APA

O, Z., T, A., G, M. U. D., ZUD, B., & S, Z. (2026). Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.. Cureus. https://doi.org/10.7759/cureus.109528

Source records